Available Positions for Postdoctoral Fellows
At NYU School of Medicine, we frequently post new opportunities for postdoctoral fellows to join our team of world-class biomedical investigators.
If you are interested in applying for an available position, please contact the principal investigator directly using the contact information included with the position listing. You might find additional postdoc opportunities by searching the NYU School of Medicine website for a researcher or department that interests you. There may be additional research opportunities available.
NYU School of Medicine researchers who have an available postdoctoral position they would like to add to this list can submit the new postdoctoral position submission form.
Current postdocs nearing the end of their appointment can log into the postdoc community using their Kerberos ID to browse a list of job openings. Faculty and administrators from outside institutions who wish to add a job opening to this list can do so by submitting a career opportunity form.
NYU School of Medicine is an equal opportunity employer committed to fostering diversity for postdoctoral fellows in the workplace. The following positions offer competitive salaries, excellent benefits, and eligibility for student housing.
Genomics of Developmental Disorders—August 15, 2019
A postdoctoral position is available immediately in the laboratory of Aravinda Chakravarti, PhD, at NYU Langone’s Center for Human Genetics and Genomics. The Chakravarti Lab focuses on the molecular genetic basis of human disease, using experimental, quantitative, and animal model approaches. A major project is on the genetic and functional dissection of Hirschsprung’s disease (HSCR), a multifactorial disorder of the enteric nervous system resulting from failure of intestinal innervation. Given our extensive gene discovery in HSCR we are now interested in the developmental mechanisms that are compromised in HSCR and, in turn, how normal innervation occurs.
The ideal candidate will hold a PhD and/or an MD in genetics or developmental biology and have some experience in genomics and computation; knowledge of human genetics is a plus. We are looking for a creative individual with a strong publication record and advanced expertise in experimental studies.
To apply or to obtain more information about the position, please contact Dr. Chakravarti at firstname.lastname@example.org. Applicants should include a CV, a one-page research statement, and the names of three references.
Neuroscience, Genomics, and Technology—August 15, 2019
The mission of the Evrony Laboratory is to understand the mechanisms by which the genome builds the brain and to identify the molecular–genetic defects underlying neuropsychiatric diseases with unknown causes. Some of the lab’s research interests and approaches include the following:
- creation of novel single-cell sequencing technologies for high-resolution lineage tracing directly in human tissues, with the goal of establishing a complete catalogue of progenitor and mature cell types in the brain
- development of genomics technologies to identify the cellular origins of individual brain tumors
- pediatric precision medicine, including advanced genomics to find the causes of unsolved diseases in children with atypical and rare conditions
We are located in Manhattan at NYU School of Medicine. Our affiliations include NYU Langone’s Center for Human Genetics and Genomics, the Department of Pediatrics, the Department of Neuroscience and Physiology, Hassenfeld Children’s Hospital at NYU Langone, and the Sackler Institute of Graduate Biomedical Sciences PhD Program.
We have positions available for postdoctoral fellows. A background in molecular and/or computational biology is recommended; however, we are building an interdisciplinary team and will consider individuals with scientific experience in other diverse fields. To apply, email a CV and a brief letter of interest to Gilad D. Evrony, MD, PhD at email@example.com.
Cancer Immunotherapy—August 12, 2019
A postdoctoral position is available in the laboratory of Daniel Meruelo, PhD, a professor in NYU Langone’s Department of Pathology, in the field of cancer immunotherapy, focusing on the capacity of oncolytic Sindbis virus vectors to stimulate the immune system against tumor cells.
Projects require proficiency with handling of mice and extraction of lymphoid organs and cells. Experience with microscopic and in vivo imaging techniques is a plus, as well as a strong background in cellular and molecular immunology. Demonstrated expertise with fluorescence-activated cell sorting (FACS) and other widely used immunological tools and assays is expected. Knowledge of molecular biology techniques, including cloning, and genomics is required. Candidates without expertise in immunology and molecular biology as demonstrated by peer-reviewed publications will not be considered.
Applicants should be recent PhD graduates or expect to receive a degree within six months. Interested candidates should send their CV and the names and contact information for three references via email to Dr. Meruelo at firstname.lastname@example.org.
Research Scientist Position in Tissue Regeneration and Translational Medicine—August 5, 2019
A research scientist position is open in the Division of Translational Medicine at NYU Langone. This position is an excellent and exciting opportunity for exposure to all aspects of translational medicine—patent law, formulation, pharmacodynamics and toxicology, clinical trials, and U.S. Food and Drug Administration regulations—while continuing to explore the basic science mechanisms related to the novel functions of calreticulin for a variety clinical applications.
The research scientist candidate will straddle between an academic laboratory at NYU School of Medicine and a start-up biotechnology company centered on tissue regeneration. Our laboratory discovered that the calcium-binding endoplasmic reticulum chaperone protein calreticulin (CRT) has profound positive biological effects on wound repair and tissue regeneration, creating an exciting new research field.
Topical application of CRT heals wounds by tissue regeneration showing epidermal appendage neogenesis, such as hair follicles, without scarring. In vitro, CRT induces migration of cells to resurface the wound, proliferation of cells to populate the wound, the production of extracellular matrix proteins to remodel and reconstruct the wound defect, removal of dead cells for wound debridement, and prevention of infection. Studies are underway to understand the mechanisms and pathways involved in these novel extracellular functions of CRT as well as structure/function relationships of the molecule.
Candidates should be able to demonstrate the ability to be creative, highly motivated, and work independently. Those with a a strong background in tissue culture, cell biology, and general molecular biology and biochemical techniques, including migration assays, are preferred.
We offer a highly enriching and interactive basic science environment and well-renowned young scientist programs that encourage independent growth. This position is limited to U.S. citizens and candidates with a green card, a current J1 visa, or another current visa. Please send curriculum vitae and at least three references to Leslie I. Gold, PhD, at email@example.com.
Melanoma, Checkpoint Inhibition, and Immunotherapy—July 30, 2019
The laboratory of Jeffrey S. Weber MD, PhD, is seeking a postdoctoral candidate in the immuno-oncology field to perform work that defines new biomarkers in patients with melanoma who are treated with checkpoint inhibition.
The postdoc works with leading academic clinicians and basic scientists in the field of flow cytometry and informatics at the intersection of genetics, tumor immunology, and bioinformatics. Our ultimate goal is to develop rational treatments to be tested in the clinic. We aim to improve our understanding of resistance to treatment with checkpoint blockade, develop novel treatments and biomarkers, identify new targets for novel therapeutics, and publish our findings in high-impact journals.
The ideal candidate has experience in molecular biology, genomic analysis, human cellular immunology, multiflow cytometry, and cell culture work. Self-motivated and innovative individuals who have experience in the field of immunology, tumor immunology, and/or oncology, and those with relevant publications, should apply.
The successful candidate has excellent written and oral communication skills, is willing to seek out grant funding from external sources, and may participate in writing grant proposals. Two years of funding are guaranteed. Interested candidates should send a CV and a brief statement of research to Kristine Buenaseda at firstname.lastname@example.org.
Bacterial Genomics and Pathogenesis—July 24, 2019
A postdoctoral fellow position is available in the Ratner Laboratory, to study the pathogenesis of group B Streptococcus (GBS) during pregnancy and in early life. Our laboratory uses bacterial genomics, small animal models of infection, and human studies to better understand GBS–host interactions and to work toward improved methods for prevention and treatment of GBS diseases.
Requirements for the position are a doctoral degree and strong training in bacterial genetics or genomics (preferably in Gram-positive organisms) and host-pathogen interactions. Specific skills required include bacterial and mammalian cell culture, animal models of infection, and bioinformatic analysis.
An excellent command of English and the desire to work within a multidisciplinary team are prerequisites. Skills with microbial community analysis and next-gen sequencing are strongly encouraged.
Applicants should email a CV, a list of three references, and a short statement describing their experience, goals, and reasons for interest in this position to Adam Ratner, MD, at email@example.com.
Wet Lab Position in Cancer Research, Genomics, and Chromosome Architecture—July 16, 2019
The Skok Lab is looking for a wet lab postdoctoral fellow to work on analyzing the impact of CTCF mutations that have been identified in cancer on chromosome architecture and gene regulation. Preferably, candidates should have experience in chromosome conformation capture (3C), CRISPR, as well as next generation sequencing techniques (ChIP-seq, RNA-seq, ATAC-seq).
The postdoc is expected to establish independent research projects and generate high impact publications, which provide excellent opportunities for further career development in academia or the pharmaceutical industry.
Motor Recovery After Stroke—June 25, 2019
A postdoctoral position is available October 1 in the Mobilis Lab of Heidi Schambra, MD, in collaboration with NYU Langone’s Department of Neurology and Rusk Rehabilitation. The Mobilis Lab is a vibrant young laboratory that aims to enhance motor recovery after stroke via targeted physical training, noninvasive brain stimulation, and neuropharmacology. Learn more about our research areas and publications.
We are currently studying the role of descending pathways in motor recovery after stroke. Using transcranial magnetic stimulation (TMS) and advanced imaging techniques, respectively, we longitudinally evaluate neurophysiology and neuroanatomy with respect to motor recovery in the paretic upper extremity. We expect the postdoctoral fellow to lead this National Institutes of Health-funded project. There are also opportunities to develop a complementary research program in noninvasive brain stimulation, motor recovery, and/or motor skill learning.
We are seeking a motivated and enthusiastic candidate with primary interests in neurophysiology and neurorecovery. Candidates must have doctoral-level experience with TMS and behavioral testing in humans, the ability to work independently and also with a collaborative interdisciplinary team, and should be comfortable working with healthy and stroke subjects. Experience with Matlab, Python, Igor, and optical motion tracking and/or Spanish language proficiency are preferred but not required.
Specific responsibilities include the following:
- acquiring and processing neurophysiology and behavioral data in human subjects
- analyzing data and synthesizing results
- presenting findings at scientific meetings
- writing and submitting manuscripts to peer-reviewed journals
- contributing to grant proposals
- mentoring students or visiting fellows
Academic development is a central feature of this fellowship, and we will actively support the fellow’s professional growth through individual development plans, one-on-one mentoring, and professional skills workshops offered though the NYU Langone Postdoctoral Training Program. The postdoctoral fellow will also have the opportunity to learn about wearable sensor technologies, machine learning, diffusion kurtosis imaging, and transcranial electrical stimulation.
Interested candidates should submit a CV; a brief cover letter explaining their research experience, interests, goals, and available start date (two pages or fewer); and the names, contact information, and roles of three references familiar with their research and academic work to Dr. Heidi Schambra at firstname.lastname@example.org.
Cancer Molecular Epidemiology—June 21, 2019
We seek talented and motivated candidates who plan to begin or expand their research career in cancer molecular epidemiology. Fellows will play a leading role in our research programs, which currently include investigations of the human microbiome and diet factors in cancer development and progression. The position offers opportunities for multi-disciplinary collaboration and professional development, including publication, presentation at scientific conferences, and involvement in proposal writing.
Candidates must hold a PhD in epidemiology or related areas. Other requirements include strong oral and written communication and quantitative skills. Experience in related laboratory work is an added strength.
Translational Leukemia Research—June 11, 2019
The Translational Leukemia Research Program at NYU Langone’s Perlmutter Cancer Center invites postdoctoral candidates to apply for positions in the laboratory of Raoul Tibes, MD, PhD, director of the Clinical Leukemia Program. The focus of the lab is the molecular-genomic characterization of primary acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPNs), their response to current therapies and novel investigational agents, and understanding the mechanisms of drug resistance.
The Tibes Lab has been instrumental in providing preclinical data based on functional genomic information for several novel treatments, including epigenetic and apoptosis targeting combinations with azacytidine and venetoclax, which were recently FDA approved for AML. The Tibes Lab is highly collaborative and our postdocs work with leading academic clinicians and basic scientists at NYU Langone, cancer centers at other academic medical centers and universities, and pharmaceutical companies to discover and delineate clinical pathways for novel therapeutic agents. Researchers from our lab publish in high-impact journals and go on to hold positions at academic institutions and biotechnology and pharmaceutical companies.
Current research projects include studying the mechanisms of antileukemic activity DNA damage repair interference by WEE1 and CHEK1 inhibition; characterizing epigenetic/hypomethylating agent resistance and the design of rational hypomethylating agent-based combinations in AML and MDS; and novel therapeutic approaches for MPNs.
The successful candidate is dedicated, independent, and able to effectively communicate research findings, as evidenced by publication in premier journals. Applicants should have a PhD (or equivalent) in molecular biology, cancer biology, or relevant fields and must be able to work independently in a fast-paced, dynamic research environment.
Our postdocs are involved in grant writing and have opportunities to submit their own career awards. They benefit from a scientifically stimulating environment with extensive resources and opportunities to collaborate at NYU Langone and externally, interact closely with primary investigators, and be actively involved in various aspects of translational cancer research and drug development.
The Tibes Lab receives funding from the National Cancer Institute, the Leukemia and Lymphoma Society, and the American Society of Clinical Oncology, as well as at the institutional level.
Our postdocs have access to world-class research facilities and opportunities at Perlmutter Cancer Center and NYU School of Medicine, one of only 17 schools to be a National Institutes of Health Broadening Experiences in Scientific Training (NIH BEST) site.
As part of a robust career development program led by NYU School of Medicine’s Office of Postdoctoral Affairs, we offer more than 30 courses and workshops on career planning, communication skills, negotiating, and conflict management, as well as career-specific training for jobs in academia, pharmaceuticals and biotechnology, science policy, medical communications, and many more.
To apply, candidates should send a letter of motivation, curriculum vitae, and the contact information of three references as a single combined PDF to Dr. Tibes at email@example.com with “Postdoctoral Application” as the subject line.
Macrophages, Adipose Tissue, and Obesity—May 3, 2019
A postdoctoral research scientist position is available immediately in NYU Langone’s Diabetes Research Program to study the underlying mechanisms of obesity, particularly macrophages and adipose tissue. Our program is dedicated to elucidating mechanisms by which the receptor for advanced glycation end products contributes to macrophage and adipocyte dysfunction in high-fat feeding.
Applicants should have a doctoral degree (PhD or MD/PhD) and solid experience with contemporary techniques in the study of obesity—specifically, the isolation and molecular and biochemical analysis of brown and white adipose tissue and the isolation and culture of adipose tissue macrophages and primary adipocytes.
Experience with cellular and molecular techniques is essential, including the isolation of primary cells from the mouse adipose tissue, liver, and skeletal muscle. Candidates should also have experience with mouse phlebotomy and glucose and insulin tolerance testing; flow cytometry and fluorescent-activated cell sorting; breeding and genotyping mice; preparation of mRNA protein lysates from tissues and cells; performance of real-time polymerase chain reaction (PCR) and Western blotting; and the principles to be applied for RNA-seq analyses.
We seek highly motivated, enthusiastic candidates who learn quickly, think creatively and independently, and work efficiently. Postdoctoral fellows train within a highly collaborative and talented group of pre- and postdoctoral research scientists.
Applicants should e-mail a CV, a list of three references, and a short statement describing their experience, goals, and reasons for interest in this position to Ann Marie Schmidt, MD, at firstname.lastname@example.org.
Human Electrophysiology of Speech—April 17, 2019
NYU School of Medicine is looking for candidates for a post-doctoral position in human electrocorticography (ECoG) research that involves investigating speech processing and cortical network dynamics under the supervision of Adeen Flinker, PhD.
The fellow works with the clinical neurology team at NYU Langone’s Comprehensive Epilepsy Center to conduct independent research that involves a population of surgical patients, who are undergoing treatment for refractory epilepsy. Patients have been implanted with intracranial electrodes or are intraoperative and undergoing acute recording or stimulation.
Applicants must have a PhD in neuroscience, psychology, biomedical engineering, or a related field. A solid background in programming, statistics, and scientific writing is required, as well as a peer-reviewed publication. The candidate is expected to work autonomously.
For more information, please contact Dr. Flinker at email@example.com.
Molecular Underpinnings of Lung Cancer—March 26, 2019
The laboratory of Kwok-Kin Wong, MD, PhD, is seeking a recent PhD graduate in the immuno-oncology field to perform groundbreaking work to elucidate fundamental understanding of the molecular underpinnings of lung cancer. Working with leading academic clinicians and basic scientists, the successful candidate will work on the interplay of genetics, tumor immune infiltration, and therapeutics in preclinical lung cancer models, with the ultimate goal of developing rational treatment hypotheses to be tested in the clinic. This work will generate understanding of drug mechanism of actions and development of novel treatments/combinations and biomarkers, and identify new targets for novel therapeutics. You will also communicate your work by writing manuscripts and publishing your results in premier journals.
We are seeking candidates with experience in molecular biology, genomic analysis, biochemistry and cell biology, in vivo pharmacology, immunology experience, multiflow cytometry, and cell culture experience. Experience with in vivo syngeneic mouse tumor models and with three-dimensional cell culture is preferred. Candidates should also possess additional qualifications as follows:
- experience in the isolation and characterization of immune cells from primary human and mouse tissues
- demonstrated scientific rigor, scientific excellence, and technical excellence
- independent, self-motivated, and innovative
- proven track record in the field of immunology/tumor immunology and/or oncology, with relevant publications
- excellent written and oral communication skills
- willing to seek out grant funding from external sources in support of independent research and may participate in writing grant proposals
- outstanding interpersonal skills, strong work ethic, and organizational skills
- ability to work productively and constructively in a team environment
- ability to excel in a goal-oriented, multifaceted, and fast-moving team environment
Interested candidates should send a CV and a brief statement of research to Christina Almonte at firstname.lastname@example.org.
Brain Tumor Research—March 26, 2019
The Brain Tumor Research Laboratory at NYU Langone is looking for a highly motivated, recent PhD graduate with strong training in biochemistry, molecular and cell biology, genetics, or cancer biology to participate in a variety of ongoing basic science, model development, and translational studies in vivo and in vitro.
We study the effect of radiation and novel targeted agents on brain tumors and seek a candidate who is intellectually and experimentally flexible and able to advance multiple projects simultaneously.
Applicants should hold a PhD in biochemistry, neuroscience, genetics, or a related discipline and have a strong background in molecular biology. Experience with mouse models is preferred. We seek applicants who are intellectually independent and who have excellent communication skills, both oral and written.
Our laboratory is located on the east side of Manhattan at NYU School of Medicine. We are affiliated with NYU Langone’s Department of Radiation Oncology and the Brain Tumor Center, part of Perlmutter Cancer Center.
The center is designed to foster interdisciplinary research at the cutting edge of human genetics and genomic technology, and hosts dedicated high-performance computing resources, sequencing, cells sorting, and other support facilities, and an automation suite with multiple liquid-handling robots enabling rapid scaling of new techniques.
To apply interested candidates should submit a letter describing their relevant experience, CV, and the names and addresses of three references to Ravesanker Ezhilarasan at email@example.com.
Pancreatic Cancer Detection, Etiology, and Treatment—March 26, 2019
Pancreatic ductal adenocarcinoma is a highly fatal malignancy that is projected to become the second leading cause of cancer-related deaths in the Unites States by 2030. The disease is characterized by delayed onset of symptoms, early metastasis, and frequent occurrence of resistance to clinically administered therapies.
The overarching goal of the Simeone Laboratory at NYU Langone is to identify mechanisms and cellular pathways that regulate pancreatic cancer initiation and progression, as well as developing novel, more effective therapeutics.
We are focusing our efforts in several areas, including the role of ataxia telangiectasia group D complement (ATDC) in pancreatic cancer development, progression, and metastasis; introducing novel therapeutic approaches for DNA damage repair (DDR) gene–mutant pancreatic cancer; and the role of the pancreas immune microenvironment in disease progression.
Diane M. Simeone, MD, is an internationally renowned physician–scientist and the director of NYU Langone’s Pancreatic Cancer Center. The Simeone Laboratory is looking to hire a postdoctoral fellow with a strong background in the fields of molecular biology, cell biology, cancer biology, or immunology.
Our lab uses multiple, advanced genomic technologies to study the mechanisms of disease progression and to understand the biology that underlies this process to define new targets for therapy. We currently employ many in vitro and in vivo approaches, including patient-derived organoids and tumor xenografts, as well as genetically engineered mouse models, to characterize and validate new targets and therapeutic strategies.
We seek individuals with a strong background in immunology, molecular biology, and biochemistry to work on projects that interrogate the role of microenvironment and the immune system in pancreatic cancer etiology and response to therapy.
Our research program is expanding and focuses on different molecular subtypes of pancreatic cancer, including homologous recombinant-deficient pancreatic ductal adenocarcinoma. The successful candidate will be a driven, creative, team-oriented individual, with a passion for translating fundamental biologic findings to the clinical setting.
Candidates should have broad experience in cell biology, biochemistry, and molecular biology. Experience with animal models (xenograft or genetically engineered mouse models) and multicolor flow cytometry analysis is valued positively.
A background in DNA damage signaling or immunology is desirable. Priority will be given to individuals with an outstanding publication record from prior graduate and/or postgraduate training and/or existing extramural funding. We welcome applications from both recent PhD recipients and individuals seeking additional postdoctoral training. Proficiency in English is required.
To apply, please submit a detailed CV, a brief statement of research interests with a description of previous research experience, and contact information (email addresses and telephone numbers) for three references to Daniel Diolaiti, PhD, at firstname.lastname@example.org. Consideration of submitted applications will start immediately and will continue until positions are filled.
The Genomic Basis of Multiple Myeloma Progression—March 19, 2019
Multiple myeloma is a cancer of the blood system. Clinically there has been much progress in improving outcomes, but 30% of cases have aggressive clinical disease that does not respond well to therapy. New targeted therapies are required to address this.
The Multiple Myeloma Program at NYU Langone is a new initiative to understand the biology of multiple myeloma and develop new therapies for this devastating illness. The program aims to utilize biological knowledge to treat high-risk multiple myeloma. We hope to prevent the development of the disease by manipulating the evolutionary trajectory of its premalignant precursor phases, which are common in the general population.
The Gareth J. Morgan Laboratory uses multiple advanced genomic technologies to study the mechanisms of disease progression and to understand the biology underlying this process to define new targets for therapy. We focus on three main areas:
- the epigenetic basis of the transition to high risk clinical
- the role of complex structural events in disease progression
- the role of the bone marrow microenvironment in disease progression
Our lab seek postdoctoral fellows who are enthusiastic, highly motivated, and creative individuals. Candidates should have a strong interest in applying multidisciplinary approaches and cutting-edge methodology to study the genetics and biology of multiple myeloma.
The fellow will benefit from a vibrant scientific environment and an outstanding medical school infrastructure that supports the most advanced technologies. We collaborate with leading researchers and offer a competitive salary and excellent benefits.
Experience in biochemistry, molecular biology, or related fields, and a strong background in routinely used molecular biology techniques are required. Proficiency in English is expected.
To apply submit a detailed CV, a brief statement of research interests with a description of previous research experience, and contact information (email addresses and telephone numbers) for three references to Dr. Gareth J. Morgan at email@example.com. Consideration of submitted applications will start immediately and will continue until positions are filled.
Carcinogenesis, Cancer Invasion, and Metastasis—March 19, 2019
The Huang Laboratory at NYU Langone’s Department of Environmental Medicine seeks to fill multiple positions that support research projects funded by the National Institutes of Health. These include postdoctoral fellowships and assistant and associate research scientist positions.
Our research projects relate to several areas and include the following topics:
- environmental lung carcinogenesis
- bladder cancer invasion and metastasis and anti-cancer activity of natural compounds at the epigenetic level
- protein kinases and transcription factor activation, target gene expression, and protein modifications both in vitro and in vivo
Candidates must have a strong background in both cellular biology and molecular biology and be highly self-motivation. Experiences in epigenetics, signal transduction, protein modification, and cancer research are preferred.
For more detailed information about our research, please see the following publications:
Zhang D., Cancer Res. 2010, 70:813; Song L., Oncogene, 2011, 30:1360; Yu Y., Oncogene, 2014, 8:996; Huang H., Clin. Cancer Res. 2015, 21:3783; Huang H., 2016, Autophagy, 12:1687; Liang Y., Autophagy, 2016, 12(8):1229; Zhou C., Oncogene, 2017, 36:3878; Peng M., Oncogene, 2018, 37:5735; Zhu J., Advanced Science, 2019; Peng M., Autophagy, 2019;
Zhu J., Oncogene, 2019.
Molecular Mechanisms of Metal Carcinogenesis—March 8, 2019
A postdoctoral position is available in NYU Langone’s Department of Environmental Medicine under the leadership of Max Costa, PhD, conducting research in molecular mechanisms of metal carcinogenesis involving a number of targets such as canonical histone polyadenylation, Nupr1 stress protein, RUNX2, microRNA, and SATB2. For more information, contact Dr. Costa at firstname.lastname@example.org.